chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received six doses of AVA from Feb 08 through Dec 09, with a booster dose administered in Dec 10. He denied any problems with previous vaccinations and denied any health related issues. Works as a Flight Engineer. He states he wears gloves and denies direct contact with chemicals. He reported that during his deployment in 2008 is when he first noticed problems with the skin on his hands. He stated the skin would become dry, scaly and cracked. He sought medical treatment and was given steroid creams and advised to keep area moisturized. He also reported that he had similar lesions on his right thigh and left leg. He noticed relief with PO and IM steroids but could not continue because he stated he developed chest pain whenever he took the steroids. Has not had chest pains since stopping steroids and his work up included EKG's which pt reported as normal. A GI evaluation in Aug 2011 noted dyspepsia, gastric linear ulceration, GERD, and hemorrhoids for which he is undergoing treatment. He reports that the lesions worsen when he applies a moisturizer, including those for sensitive skin and without fragrances. His labs including an ANA were unremarkable.
Lower back pain,  joint pain, hip and upper thigh pain. ER visit 3/21/21. Sent home with pain relievers and told it was a muscle spasm. Urgent care visit 04/09/21. Told it may be sciatica nerve. Advised to seek a chiropractor.
dizziness an hour after shot? lasted for 15-20 minutes. throat tightening around 9:30-10:30pm day of shot? feeling uncomfortable but not fully closing. Three days after shot, 9/18/2022 around 5am symptoms of nausea and diarrhea and some vomiting ? this lasted nearly 4 days. as well, shortness of breath, fever, unwavering migraine, and covid-like illness symptoms for up to two weeks, ending 9/28/2022 or 9/29/2022. Cough lingered strongly  until 10/02/2022
HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23.; Vaccine was administered to patient after temperature excursion occurred.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event) in a 74-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 05D22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Prostate cancer.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23.) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.).    Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine were unknown. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-730480 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730480:Same reporter
Initial misuse report received from health care professional on 23 October 2013. A 66-year-old male patient received a dose of FLUZONE ID. (No other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none
The patient had generalized erythema with swelling, it started one day after his vaccinations.
Swelling above her clavicle; Developed a nodule that was not there before; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling above her clavicle) and NODULE (Developed a nodule that was not there before) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling above her clavicle) and NODULE (Developed a nodule that was not there before). At the time of the report, SWELLING (Swelling above her clavicle) and NODULE (Developed a nodule that was not there before) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Shakiness-Mild, Systemic: Tinnitus-Mild
This is my 3rd pregnancy, history of gestational diabetes and preterm labor, EDD 2/1/22, 20 week ultrasound found no abnormalities. Only symptom to report was pain at the injection site for 3 days, starting on the day of the injection, a few hours after the injection. .
I had 3 bright spots that look like vaccine injections.  The left arm has large bruising under site.  Stuff nose.
PATIENT DEVELOPED ALLERGY, HIVES AND ITCHY SKIN EDEMA.  PATIENT END UP HOSPITALIZED TWICE FOR A TOTAL OF 7 DAYS. SHE WAS TREATED WITH ZYRTEC 10MG AND ATARAX.
After the second shot, I had a fever and body aches. I got better after 2 days, then got worst. Then I started having trouble with my eyes. My eyes would get very blurry. No eye drops work. I had itchy skin. My eye are still having problems. Was diagnosed Filamentary Keratitis and Keratoconjunctivitis Sicca of both eyes. My eyes are dry as well.
10-22-2021Within 3 hours sever headache started  10-23-2021 am starting feeling flu like symptoms and severe muscle ache along with headache  Issues continued thru 10/27/2021 10/27/2021 severe headache and fever started along with nausea  10/28/2021 cluster headache and body aches
Patient received #1 Pediarix, #1 HIB and #1 Prevnar on 08/02/2005 at 14:25. About 2-3 hours after vaccination patient became very fussy, cranky unconsolable screaming and 2-3 hours she slept. 1-2 hours was screaming and lethargic per mother. She was given Tylenol from 08/02/05 to 08/03/05. Mother had to have plain vaccine no pertussis.
Contracted Covid. Symptoms began on 6/28. I thought it was a reaction to prednisone, which I had just started for a severe rash. Scratchy throat. Progressed to congestion. Severe congestion developed on day 4 and cough for two weeks. Cough is still lingering one month later. I am not normally on prednisone, and since I had just started it, did not list it as a medication because it was only for two weeks? So I was taking prednisone while experiencing Covid symptoms. No fever. No fatigue.
Feels so bad had to miss work; Chills in warm house; pounding headache; Achiness; Queasy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels so bad had to miss work), CHILLS (Chills in warm house), HEADACHE (pounding headache), MYALGIA (Achiness) and NAUSEA (Queasy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced CHILLS (Chills in warm house), HEADACHE (pounding headache), MYALGIA (Achiness) and NAUSEA (Queasy). On 05-Feb-2021, the patient experienced FEELING ABNORMAL (Feels so bad had to miss work). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 04-Feb-2021 for Headache, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Feels so bad had to miss work), CHILLS (Chills in warm house), HEADACHE (pounding headache), MYALGIA (Achiness) and NAUSEA (Queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
09/07/2001 Patient developed temperature of 102. Complained of stomach ache, dull constant pain and lethargy. Symptoms and temperature persisted for 5 days. 09/11/2001 Mom called PHN; referred patient to MD.  Throat culture and chest x-ray done. 09/12/2001 Temp of 104.
Client noticed itching and swelling at injection site over 24 hours later. Cont today (8-22-13) with same. States feels warm and has redness the size of a 50 cent piece. No systemic symptoms, no fever. Advised to see PCP if getting worse instead of better.
Information has been received from a medical assistant concerning a patient who approximately one month ago on 03-APR-2007 was vaccinated with a dose of zoster vaccine live. Within a week, the patient died of a heart attack. No additional information was provided. Additional ifnormation has been requested.  5/18/07 Received records from reporter which included Death Certificate which reveals COD as Inferior myocardial infarction. Records from PCP incidate patient had tetanus updated 1/24/07. Records from ER of 3/16/07 indicate patient seen for syncope or unresponsiveness when passed out in church after complaining to friends that she did not feel well for several days because of her gallbladder.  EMS called.  BP was unobtainable.  Started on Dopamine & given IV fluid bolus.  Denied pain & good respiratory effort but restless.  O2 sats remained in high 80's but w/poor perfusion signal.  Preparing to administer thrombolytics when became unresponsive & lost pulse.  Intubated & coded but unsuccessful resuscitation. FINAL ER DX: acute myocardial infarction, perhaps remote w/continued expansion of infarct leading to cardiopulmonary decline.
Adverse event started the next day, patient c/o 102 degree temp, extreme muscle pain, severe arm pain still going on at injection site (muscle).
The day of the 2nd dose I had a reaction as if I ate something I'm allergic to. The spot where the vaccine was injected was itchy on my skin and inside of my muscle but I can't scratch that. My throat also got itchy but I had brought my medication just in case and took benadryl.  The staff told me to sit a while until I felt better before I left.   Now however, several months later, my whole arm is itchy and painful at the area where the vaccine was injected and I'm concerned because it is now sore to the touch as well and inside my arm is itching again. I can't exactly scratch my bones but that's what it feels like would give me relief. My throat is also itchy which could mean I simply ate something that is giving me a reaction so I'll take cetirizine but that would not explain the itch on my left arm exactly where I received the shot. My temperature is usually on the lower side, 96.5 but right now it's 99. Do I need a booster shot? Why is my body reacting to the vaccine now again?
Flu shot was administered in AM - following morning right arm was very sore & movement restricted. Got worse until it was necessary to see a doctor. Was given an antibiotic for infection.
3 inch diameter-sized rash at injection site appeared 7 days after vaccination. The rash feels warm to the touch, skin feels hard, and itchy.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, in Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 15Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "immune system compromise" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; HYDROXYCHLOROQUINE. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (09May2022) Positive, notes: Home test positive. Therapeutic measures were taken as a result of covid-19.  Additional Information: COVID 19 Treatment with Paxlovid with start date 20Apr202 and stop date 24Apr2022. Adverse event: Rebound symptoms / internet shows it could happens. Home test positive. Adverse event start date: 09May2022. No treatment received. No known allergies present. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
07/01/22 presents to emergency room for "altered mental status". PMHx of "DMT1, PE/DVT, and HLD".
2nd booster (4th shot) given on 7/5 in right deltoid. Pt had all moderna vaccines without reaction but this time on 7/8 she developed area of raised erythema, warmth, itchy rash on the right arm from deltoid down lateral arm to elbow, consistent with large local hypersensitivity reaction. no s/sx systemic reaction or anaphylaxis.
Client received rabies pre-exposure vaccinations for employment as Animal Control Officier.  Rabies vaccine Imovax  Lot #W1419-3 expiration date of 12-06-05.  This lot was recalled on 04-05-04.  The vaccine was administered on 02-27-04.  the client was contacted on Wednesday, April 7th, 2004 and informed of the recall and suggested treatment was discussed.  Client chose recommended treatment of 2 additional doses of rabies vaccine 3 days apart.  Clients only complaint after 1st additional dose was a headache.  Client signed agreement to receive prophylactic treatment.
stroke; super disoriented and his body pulls to the right; has no taste in his mouth; This is a spontaneous report from a contactable consumer (patient's wife). A 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 24Sep2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller reported that her husband had a stroke during the weekend on an unspecified date. He was released from the hospital yesterday (unspecified date). He does therapy at home. He was super disoriented, and his body pulls to the right. He also had no taste in his mouth, has a difficult time differentiating taste. The patient was scheduled to get his second dose of Pfizer vaccine however he does not know he should proceed. The patient was hospitalized for stroke (cerebrovascular accident) from an unknown date to 13Oct2021 for 3 days. The outcome of all events was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
L arm started itching 7 days post vaccine. That night I noticed it was red, hot, and swollen. It was also hard like maybe an abbess/hematoma under injection site. I called occupational health at my hospital which then directed me to call my PCP to be seen. I saw my PCP and was prescribed Bactrim
Rash, itchy, red. Spread all over body over the course of two weeks, including legs, back, arms, chest, face. Used prescribed creams from dermatologist, benadryl, and claritin. After four weeks of treatment, rash still remains on legs.
Right lower quadrant pain over 24 hours.  Diagnosed with appendicitis via CT scan and underwent lap appendectomy.  Symptoms resolved post-op
Sore arm; headache; This is a spontaneous report from a non-contactable consumer. A 50-year-old female patient received received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), intramuscular at single dose into the left arm on 20Jan2021 for COVID-19 immunization. Medical history and concomitant drugs were unknown. On 20Jan2021 the patient experienced sore arm and headache. No treatment for the events was received.  At the time of reporting the patient was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
severe attack; breathing difficult; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the parent.  A 39 year-old female patient received bnt162b2 (BNT162B2), administration date 06Jan2022 (Batch/Lot number: unknown) at the age of 39 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (hospitalization) with onset 10Jan2022, outcome "unknown", described as "severe attack"; DYSPNOEA (non-serious), outcome "unknown", described as "breathing difficult". The event "severe attack" was evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: investigation: unknown results; unknown results.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Headache; Slightly sore arm; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (Headache) and VACCINATION SITE PAIN (Slightly sore arm) in a 69-year-old female patient who received mRNA-1273 (batch nos. 012L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Slightly sore arm). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) and VACCINATION SITE PAIN (Slightly sore arm) had resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.   This case was linked to MOD-2021-223785 (Patient Link).
5SEP96 t104 w/sz lasting 10-15min;6SEP96 seen by MD no problem noted;
This case was reported by a healthcare professional (a nurse, also the subject) and described the occurrence of anaphylactic reaction in a 51-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). Concurrent medical conditions included latex allergy. There were no concurrent medications. In October 2010 the subject received unspecified dose of FLUARIX at 0.5 cc in the left arm. Quickly following administration of FLUARIX, the subject went into an anaphylactic reaction (thought to be latex allergy related). She developed tightening in her throat and chest. The subject had not known that there was latex involved with the 2010 flu vaccine. The subject was treated at her office with epinephrine and transported to the emergency room (ER) via ambulance. Oxygen was administered in the ambulance and the ER. The subject was discharged from the ER with the reaction resolving. It was noted that the anaphylactic reaction ended 2 to 3 days later. The healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). It was noted that the reporter felt that the anaphylactic reaction was probably related to treatment with FLUARIX, but attribution for throat tightness and chest tightness was not specifically mentioned.
injection site pain; nasty headache now; body pain; Nausea; fever; shakes; fatigue; her upper right arm started hurting bad; sore legs; no smell; back pain; sore throat; she has no appetite; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her upper right arm started hurting bad), PAIN IN EXTREMITY (sore legs), ANOSMIA (no smell), BACK PAIN (back pain) and OROPHARYNGEAL PAIN (sore throat) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She had COVID on 18 Dec 2020 and recovered in 3 weeks.) on 18-Dec-2020. Concurrent medical conditions included Asthma on 01-Nov-2007 and Allergies (Iodine,  Shellfish).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (her upper right arm started hurting bad), PAIN IN EXTREMITY (sore legs), ANOSMIA (no smell), BACK PAIN (back pain), OROPHARYNGEAL PAIN (sore throat), DECREASED APPETITE (she has no appetite), NAUSEA (Nausea), PYREXIA (fever), CHILLS (shakes) and FATIGUE (fatigue). On 27-Jan-2021 at 8:30 AM, the patient experienced PAIN (body pain). On 28-Jan-2021, the patient experienced HEADACHE (nasty headache now). On 29-Jan-2021 at 5:30 AM, the patient experienced INJECTION SITE PAIN (injection site pain). At the time of the report, PAIN IN EXTREMITY (her upper right arm started hurting bad), PAIN IN EXTREMITY (sore legs), ANOSMIA (no smell), BACK PAIN (back pain), OROPHARYNGEAL PAIN (sore throat), DECREASED APPETITE (she has no appetite), PAIN (body pain), NAUSEA (Nausea), PYREXIA (fever), CHILLS (shakes), FATIGUE (fatigue), HEADACHE (nasty headache now) and INJECTION SITE PAIN (injection site pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Pyrexia: 100.9 °F (High) ranged from 100.9F - 101.3 F. On 29-Jan-2021, Pyrexia: 99 °F High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications include Tylenol with codeine and 1 tablet Flexeril muscle relaxant and hydration.